Table 17 Antibacterial activities of synthesized compounds
From: Biological potential of thiazolidinedione derivatives of synthetic origin
Compounds | MIC ± SLM (μg/ml) | |
|---|---|---|
E. coli | B. subtilis | |
56 | 20.75 ± 1.55 | 35.41 ± 2.41 |
57 | 19.41 ± 1.27 | 26.00 ± 1.96 |
58 | 8.58 ± 0.42 | 8.42 ± 0.51 |
Ciprofloxacin | 25.00 ± 0.95 | 50.00 ± 1.75 |